| __timestamp | Perrigo Company plc | Ultragenyx Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 152500000 | 45967000 |
| Thursday, January 1, 2015 | 187800000 | 114737000 |
| Friday, January 1, 2016 | 184000000 | 183204000 |
| Sunday, January 1, 2017 | 167700000 | 231644000 |
| Monday, January 1, 2018 | 218600000 | 293998000 |
| Tuesday, January 1, 2019 | 187400000 | 357355000 |
| Wednesday, January 1, 2020 | 177700000 | 412084000 |
| Friday, January 1, 2021 | 122000000 | 497153000 |
| Saturday, January 1, 2022 | 123100000 | 705789000 |
| Sunday, January 1, 2023 | 122500000 | 648449000 |
In pursuit of knowledge
In the competitive world of pharmaceuticals, innovation is key. Over the past decade, Ultragenyx Pharmaceutical Inc. and Perrigo Company plc have shown contrasting approaches to research and development (R&D) investments. From 2014 to 2023, Ultragenyx has consistently increased its R&D spending, peaking at a staggering 705% increase from its 2014 levels by 2022. This commitment underscores Ultragenyx's focus on pioneering treatments and cutting-edge research.
Conversely, Perrigo's R&D investment has seen a more conservative trajectory, with a peak in 2018 and a subsequent decline, reflecting a strategic shift towards optimizing existing product lines. By 2023, Perrigo's R&D expenses had decreased by approximately 20% from their 2018 peak.
This data highlights the divergent strategies of these two industry players, offering insights into their future directions and potential market impacts.
Research and Development Investment: Eli Lilly and Company vs Perrigo Company plc
R&D Insights: How AstraZeneca PLC and Ultragenyx Pharmaceutical Inc. Allocate Funds
Research and Development Expenses Breakdown: Gilead Sciences, Inc. vs Perrigo Company plc
Research and Development: Comparing Key Metrics for argenx SE and Ultragenyx Pharmaceutical Inc.
R&D Insights: How Jazz Pharmaceuticals plc and Ultragenyx Pharmaceutical Inc. Allocate Funds
R&D Spending Showdown: Blueprint Medicines Corporation vs Ultragenyx Pharmaceutical Inc.
Amneal Pharmaceuticals, Inc. or Ultragenyx Pharmaceutical Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Ultragenyx Pharmaceutical Inc. and Vericel Corporation
R&D Spending Showdown: Ultragenyx Pharmaceutical Inc. vs Xencor, Inc.
Research and Development: Comparing Key Metrics for PTC Therapeutics, Inc. and Perrigo Company plc
R&D Spending Showdown: Perrigo Company plc vs MannKind Corporation
Perrigo Company plc vs Wave Life Sciences Ltd.: Strategic Focus on R&D Spending